Sader, H S <br/><br/>
Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015-2018).  [electronic resource] 

 -  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases  May 2020 
 - 658-659 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1469-0691 
<br/><br/><label>Standard No.: </label>10.1016/j.cmi.2019.12.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Cephalosporins--pharmacology<br/>Humans<br/>Methicillin-Resistant Staphylococcus aureus--drug effects<br/>Microbial Sensitivity Tests--standards<br/>Staphylococcal Infections--drug therapy<br/>United States--epidemiology<br/>Ceftaroline